1132638-65-3

Basic information

• Product Name: N^β-(1-benzylpiperidin-4-yl)quinoline-3,4-diamine
• Synonyms: N^β-(1-benzylpiperidin-4-yl)quinoline-3,4-diamine
• CAS NO: 1132638-65-3
• Molecular Weight: 332.448
• Mol File: 1132638-65-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N^β-(1-benzylpiperidin-4-yl)quinoline-3,4-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: N^β-(1-benzylpiperidin-4-yl)quinoline-3,4-diamine(1132638-65-3)
• EPA Substance Registry System: N^β-(1-benzylpiperidin-4-yl)quinoline-3,4-diamine(1132638-65-3)

Safety Data

• Hazardous Substances Data: 1132638-65-3(Hazardous Substances Data)

Upstream product

• 1132638-64-2 (1-benzylpiperidin-4-yl)-(4-nitro-1-oxyquinolin-3-yl)-amine 
• 22615-00-5 3-bromoquinoline N-oxide 
• 14173-58-1 3-bromo-4-nitroquinoline 1-oxide 
• 5332-24-1 3-bromoquinoline 

Relevant articles and documents

Novel Compounds

The present invention relates to the new compounds of general formula I wherein A, U, V, X, Y, R1, R2 and R3 are defined as stated hereinafter, the tautomers, the isomers thereof, the diastereomers, the enantiomers, the hydrates, the mixtures and the salts thereof as well as the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, their use and processes for preparing them.

CGRP ANTAGONISTS

The present invention relates to new CGRP-antagonists of general formula I wherein U, V, X, Y, R1, R2 and R3 are defined as stated hereinafter, the tautomers, the isomers, the diastereomers, the enantiomers, the hydrates, the mixtures thereof and the salts thereof and the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, their use and processes for preparing them.